Hinge Health, Inc. (HNGE) Stock
NYSE · HNGE
92.52
Fundamentals
Market cap
$7.71B
Price / Earnings ratio
69.1x
Price / Sales ratio
10.3x
Price / Book ratio
21.6x
Return on assets
-70.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
NeutralHNGESeptember 21, 2026
Zacks Investment ResearchNeutral
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE

CNBC
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
NeutralHNGESeptember 8, 2026
CNBCNeutral
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
HNGE

The Motley Fool
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
NeutralHNGESeptember 4, 2026
The Motley FoolNeutral
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
HNGE

Zacks Investment Research
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
NeutralHNGESeptember 3, 2026
Zacks Investment ResearchNeutral
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
HNGE
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Buy12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral1
Buy11
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
705M466M233M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
894M590M295M0
Revenue to Profit
2025$587.9M
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-528.3M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
NeutralHNGESeptember 21, 2026
Zacks Investment ResearchNeutral
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE

CNBC
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
NeutralHNGESeptember 8, 2026
CNBCNeutral
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
HNGE

The Motley Fool
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
NeutralHNGESeptember 4, 2026
The Motley FoolNeutral
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
HNGE

Zacks Investment Research
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
NeutralHNGESeptember 3, 2026
Zacks Investment ResearchNeutral
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
HNGE

MarketBeat
One Platform, Every Ailment: Hinge Health's Gamble
NeutralHNGEAugust 20, 2026
MarketBeatNeutral
One Platform, Every Ailment: Hinge Health's Gamble
HNGE

Zacks Investment Research
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
NeutralHNGEAugust 19, 2026
Zacks Investment ResearchNeutral
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
HNGE

Zacks Investment Research
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
NeutralHNGEAugust 14, 2026
Zacks Investment ResearchNeutral
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE

Zacks Investment Research
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
NeutralHNGEAugust 12, 2026
Zacks Investment ResearchNeutral
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
HNGE

Zacks Investment Research
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
NeutralHNGEAugust 12, 2026
Zacks Investment ResearchNeutral
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE

Zacks Investment Research
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
NeutralHNGEAugust 12, 2026
Zacks Investment ResearchNeutral
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
HNGE
About Hinge Health, Inc.
No description available.
SectorHealthcare
IndustryHealth Information Services
Employees1,437
CEOMr. Daniel A. Perez
IPO DateMay 22, 2025
HeadquartersSan Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Gabriel Mecklenburg | Co-Founder, CTO & Executive Chairman | 1989 |
| Mr. Daniel A. Perez | Co-Founder, CEO & Director | 1986 |
| Mr. James Pursley | President | 1980 |
| Mr. James W. Budge | Chief Financial Officer | 1967 |
| Mr. Alexander Annison | Chief Operating Officer | — |
| Bianca Buck | Finance & Head of Investor Relations | — |
| Mr. David Wood | General Counsel | — |
| Ms. Erin Wilson | Senior Vice President of Sales & Strategy | — |
| Dr. Jeffrey Krauss M.D. | Chief Medical Officer | — |
| Mr. Hassan Asghar | Chief Information Security Officer | — |
Fundamentals
Valuation
Market cap$7.71B
Price-to-sales ratio10.31
Price-to-book value21.56
Price-earnings ratio69.10
Return on Equity-304.00%
Return on Sales-79.00%
Return on Assets-70.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$3.07
Income Statement
Average volume2,017,441
EBITDA$-500.96M
1 year high (52w)$96.66
1 year low (52w)$30.08
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Buy12 Indicators
What the experts say
12 Wall Street Analyst Ratings
BUY
92% Buy
8% Hold
0% Sell
Target price
$106.00
Est return
13.56%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +3.4 | +27.9 | -0.8 | +24.8 | -11.9 | +2.1 | -2.8 | -3.1 | ||||
| 2026 | -23.4 | +21.4 | -14.0 | +15.9 | +23.7 | +36.2 | -12.2 | +19.2 | +6.2 |



